Find more information about BEXSERO (Meningococcal Group B Vaccine). Find details about clinical data, safety profile, dosing and more.
Find more information about BEXSERO (Meningococcal Group B Vaccine). Find details about clinical data, safety profile, dosing and more.
Find more information about BEXSERO (Meningococcal Group B Vaccine). Find details about clinical data, safety profile, dosing and more.
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
The choice of dosing schedule may depend on the risk of exposure and the individual’s susceptibility to meningococcal serogroup B disease. 2.2 Administration Shake the syringe immediately before use to form a homogeneous suspension. Do not use the vaccine if it cannot be resuspended. Parenteral dru...
In August 2024, the Food and Drug Administration (FDA) changed the label for the meningococcal serogroup B MenB-4C vaccine (Bexsero) from a 2-dose schedule (intervals of 0 and ≥1 month) to a 2-dose schedule (0 and 6 months) and added a 3-dose schedule (0, 1-2...
Find more information about BEXSERO (Meningococcal Group B Vaccine). Find details about clinical data, safety profile, dosing and more.